Jefferies Starts Questcor Pharmaceuticals (QCOR) at Buy
Tweet
Share
E-mailGet Alerts QCOR Hot Sheet
Price: $93.60 --0%
Rating Summary:
5 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 2
Rating Summary:
5 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 2
Join SI Premium – FREE
Jefferies initiates coverage on Questcor Pharmaceuticals (NASDAQ: QCOR) with a Buy. PT $36.00.
The firm states, "We believe the next leg of Acthar's growth story should come from the nephrotic syndrome market where the company recently announced a major marketing initiative. The multiple sclerosis market should continue to grow at a healthy trajectory and will likely be the key sales driver in the near-term."
For more ratings news on Questcor Pharmaceuticals click here and for the rating history of Questcor Pharmaceuticals click here.
Shares of Questcor Pharmaceuticals closed at $27.80 yesterday.
The firm states, "We believe the next leg of Acthar's growth story should come from the nephrotic syndrome market where the company recently announced a major marketing initiative. The multiple sclerosis market should continue to grow at a healthy trajectory and will likely be the key sales driver in the near-term."
For more ratings news on Questcor Pharmaceuticals click here and for the rating history of Questcor Pharmaceuticals click here.
Shares of Questcor Pharmaceuticals closed at $27.80 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Starts Kanzhun Ltd (2076:HK) at Overweight
- Deutsche Bank Resumes Kloeckner & Co SE (KCO:GR) at Hold
- Emkay Global Starts Vedanta Aluminium Metal (VAML:IN) at Buy (1)
Create E-mail Alert Related Categories
New CoverageRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
